欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/4021/003
药品名称Levodopa/Carbidopa/Entacapon AbZ 100 mg/25 mg/200 mg Filmtabletten
活性成分
    • Carbidopa 25.0 mg
    • Entacapone 200.0 mg
    • levodopa 100.0 mg
剂型Film-coated tablet
上市许可持有人AbZ-Pharma GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Levodopa/Carbidopa/Entacapone AbZ 100 mg/25 mg/200 mg Filmtabletten
互认成员国 - 产品名称
    • Latvia (LV)
    • Lithuania (LT)
      Levodopa/Carbidopa/Entacapone Teva 100 mg/25 mg/200 mg plėvele dengtos tabletės
    • Estonia (EE)
      LEVODOPA/CARBIDOPA/ENTACAPONE TEVA
    • Hungary (HU)
      LEVODOPA/CARBIDOPA/ENTACAPONE TEVA 100 mg/25 mg/200 mg filmtabletta
    • Romania (RO)
      Levodopa Carbidopa Entacapona Teva 100 mg/25 mg/200 mg comprimate filmate
    • Netherlands (NL)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
许可日期2014/07/08
最近更新日期2024/11/20
药物ATC编码
    • N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase